Helicobacterpyloritest.com - Breath test system

H. pylori Test Home>Professionals>Introduction

Introduction

Infection of H. pylori is associated with peptic ulcer disease, gastric adenocarcinoma, and mucosa associated lymphoid tissue (MALT) lymphoma. The World Health Organization categorizes H. pylori as a group I or definite human carcinogen. Over the course of the last few years, testing for H. pylori in symptomatic patients has become standard practice.

The BreathID System is intended for use in the qualitative detection of urease associated with Helicobacter pylori in human stomach and as an aid in initial diagnosis and post treatment monitoring of H. pylori infection in adult patients. With exceptional sensitivity of 100% and specificity of 99.2% , this system features accuracy that is unmatched by traditional H. pylori tests currently available, thereby giving full confidence in the results you receive.

H. pylori Resources

Disclaimer: The BreathID System is intended for use in the qualitative detection of H. pylori. It has an approved 510(K) and an approved NDA for the ¹³ C-urea Tablet and Citrica Powder.

Helicobacter pylori is a bacteria which may reside in the patient’s stomach, and may lead to peptic ulcer disease and stomach cancer. H. pylori infection is highly prevalent . Symptoms of H pylori include gastritis, dyspepsia , bloating, belching and more. The only way to know for sure if H. pylori is present is to be tested, as patients may be asymptomatic. H. pylori can be detected by a blood antibody test , a 13C-urea breath test and a stool test. The BreathID Breath Test System may be used as an aid in the detection of helicobacter pylori bacteria and in post treatment monitoring, through a ¹³C-urea breath test. The ¹³C-urea Breath Test is a simple, non-invasive testing option to detect H. pylori and with the BreathID Hp FasTest ^TM . The test has a sensitivity of 99.2% and a specificity of 100% in detecting active Helicobacter pylori infection.

Site by Moonsite